Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Update

Check-Cap Ltd. (NASDAQ:CHEK) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 9,900 shares, an increase of 7.6% from the November 30th total of 9,200 shares. Based on an average daily trading volume, of 690,100 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.2% of the company’s stock are sold short.

Check-Cap Price Performance

Check-Cap stock traded down $0.16 during mid-day trading on Wednesday, reaching $0.99. 173,603 shares of the company traded hands, compared to its average volume of 257,456. The firm’s fifty day moving average is $0.94 and its two-hundred day moving average is $1.51. The company has a market capitalization of $5.79 million, a price-to-earnings ratio of -0.33 and a beta of 0.25. Check-Cap has a fifty-two week low of $0.56 and a fifty-two week high of $3.45.

Analyst Ratings Changes

Separately, StockNews.com started coverage on Check-Cap in a report on Friday, December 27th. They issued a “sell” rating for the company.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.